Literature DB >> 12044015

A history of prostate cancer treatment.

Samuel R Denmeade1, John T Isaacs.   

Abstract

The increased incidence of prostate cancer has led to remarkable changes in diagnosis and treatment over the past century. What were the first ways in which prostate cancer was treated, and how did these evolve into the variety of therapeutic strategies from which patients have to choose today?

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12044015      PMCID： PMC4124639          DOI： 10.1038/nrc801

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  66 in total

1.  Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma.

Authors:  G Chodak; R Sharifi; B Kasimis; N L Block; E Macramalla; G T Kennealey
Journal:  Urology       Date:  1995-12       Impact factor: 2.649

2.  Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer.

Authors:  J W Simons; B Mikhak; J F Chang; A M DeMarzo; M A Carducci; M Lim; C E Weber; A A Baccala; M A Goemann; S M Clift; D G Ando; H I Levitsky; L K Cohen; M G Sanda; R C Mulligan; A W Partin; H B Carter; S Piantadosi; F F Marshall; W G Nelson
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

3.  Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells.

Authors:  C M Jakobsen; S R Denmeade; J T Isaacs; A Gady; C E Olsen; S B Christensen
Journal:  J Med Chem       Date:  2001-12-20       Impact factor: 7.446

4.  Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Authors:  C Huggins; C V Hodges
Journal:  CA Cancer J Clin       Date:  1972 Jul-Aug       Impact factor: 508.702

5.  Ultrasound-guided prostate biopsy. Biopty gun superior to aspiration.

Authors:  H Ragde; H C Aldape; C M Bagley
Journal:  Urology       Date:  1988-12       Impact factor: 2.649

6.  Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

Authors:  D M Savarese; S Halabi; V Hars; W L Akerley; M E Taplin; P A Godley; A Hussain; E J Small; N J Vogelzang
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

7.  Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors:  G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

8.  Leuprolide versus diethylstilbestrol for metastatic prostate cancer.

Authors: 
Journal:  N Engl J Med       Date:  1984-11-15       Impact factor: 91.245

9.  Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations.

Authors:  P C Walsh; H Lepor; J C Eggleston
Journal:  Prostate       Date:  1983       Impact factor: 4.104

10.  Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Authors:  A Sella; R Kilbourn; R Amato; C Bui; A A Zukiwski; J Ellerhorst; C J Logothetis
Journal:  J Clin Oncol       Date:  1994-04       Impact factor: 44.544
View more
  141 in total

1.  Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells.

Authors:  Shuai Tang; Miranda L Moore; Jason M Grayson; Purnima Dubey
Journal:  Cancer Res       Date:  2012-02-28       Impact factor: 12.701

2.  Androgen mediated translational and postranslational regulation of IGFBP-2 in androgen-sensitive LNCaP human prostate cancer cells.

Authors:  David J Degraff; Adam A Aguiar; Qian Chen; Lisa K Adams; B Jill Williams; Robert A Sikes
Journal:  Am J Transl Res       Date:  2010-03-06       Impact factor: 4.060

Review 3.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

4.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 5.  Rationale for the development of alternative forms of androgen deprivation therapy.

Authors:  Sangeeta Kumari; Dhirodatta Senapati; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2017-05-31       Impact factor: 5.678

6.  Androgen deprivation by activating the liver X receptor.

Authors:  Jung Hoon Lee; Haibiao Gong; Shaheen Khadem; Yi Lu; Xiang Gao; Song Li; Jian Zhang; Wen Xie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 7.  Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer.

Authors:  Paul J Toren; Martin E Gleave
Journal:  Asian J Androl       Date:  2013-04-15       Impact factor: 3.285

Review 8.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

9.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

10.  A Dual-Frequency Colinear Array for Acoustic Angiography in Prostate Cancer Evaluation.

Authors:  Sibo Li; Jinwook Kim; Zhuochen Wang; Sandeep Kasoji; Brooks D Lindsey; Paul A Dayton; Xiaoning Jiang
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2018-10-01       Impact factor: 2.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.